In this episode, I’m talking to Dani, a PA who has spent the last decade working with GLP-1 medications and obesity treatment — long before most people had even heard of them.
We talk about why obesity is still so misunderstood, the emotional side of weight loss treatment, and how explaining obesity as a chronic disease can completely change the way patients see themselves. Dani shares what she’s learned from years of working with people struggling with metabolic health, binge eating, shame, and the feeling that nothing works no matter how hard they try.
We also dive into semaglutide, tirzepatide, dosing strategies, maintenance, compounded medications, and why sustainable treatment often matters more than rapid weight loss. Along the way, we discuss misinformation around GLP-1s, the future of obesity medicine, and why these medications may impact far more than just weight in the years ahead.
A grounded, compassionate conversation about what real obesity care should actually look like — both medically and emotionally.
","author_name":"The Weight Medicine Podcast"}